INREBIC

fedratinib hydrochloride · Celgene Corporation

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for INREBIC, covering 2019-08-16 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Inrebic (fedratinib dihydrochloride monohydrate) — Bristol Myers Squibb Pharma EEIG